CME Credits

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Community Health Network and Kukuna-O-Ka-La Radiation. 

Community Health Network is accredited by the Indiana State Medical Association to provide continuing medical education for physicians. Community Health Network designates this Live Activity for a maximum of 20.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


At the completion of this activity, participants should be able to:

  1. Adaptive therapy: Describe the different modalities for adaptive therapy, the workflow and time commitment and the literature supporting adaptive therapy.
  2. HPV positive Oropharynx Cancer: Summarize the evolution of treatment and current standards of care, compare ongoing trials of de-escalation, and outline ongoing trials regarding monitoring and surveillance.
  3. Post-operative Therapy for Oral Cavity Cancers: Where can we add and where can we subtract?: Summarize surgical approaches including use of sentinel node biopsy and flap reconstruction, evaluate the supporting data for radiation and chemoradiation and outline ongoing trials regarding increasing and decreasing treatment for high and low risk cancers.
  4. Radiation Toxicities: Manage some commonly encountered subacute and chronic toxicities in radiation oncology: Recognize the most common subacute and chronic radiation toxicities, gain familiarity with practical issues in diagnosing and managing toxicities, and learn about future options in management.
  5. Cervical Cancer: Review immunotherapy data, side effects of radiation therapy and embrace data, and discuss next steps including hypofractionation and interstitial brachytherapy.
  6. Endometrial Cancer: Review updates on molecular markers and their prognostic significance, the open protocols on molecular markers and how to use results to personalize treatment and review treatment options for recurrent disease.
  7. Ovary, Vagina and Neuroendocrine Tumors: Discuss indications, fields and dose for recurrent ovarian cancer, the role for radiation in neuroendocrine tumors and the updates on treatment in vaginal cancers including prognostic factors and molecular markers.
  8. Vulvar Cancers: Discuss the update on GROINS and how it has changed management, update on the indications for postoperative treatment especially as considers close or positive margins and discuss pitfalls and advantages of VMAT/IMRT including contouring and imaging.
  9. Diagnosis, Management and Novel Therapies for Low Grade and High-Grade Gliomas: Discuss the prognostic and predictive value of molecular classification and the imaging for treatment planning and monitoring, modern treatment planning and role of reirradiation.
  10. Modern Management of Brain Metastases: Implement stratification algorithms for limited and extensive brain metastases, standard and advanced imaging for planning and monitoring, learn advances in systemic therapy and individualized plans for leptomeningeal disease and cognitive sparing techniques.
  11. The Role of Radiotherapy in Benign CNS: Implement modern techniques including proton therapy for skull-based tumors, individualize radiosurgery plans for benign indications and use molecular classification for dose painting, shaping and dose escalation for meningioma radiotherapy.
  12. Modern Management of Spine Tumors: Spine SBRT and Beyond: Implement modern spine SBRT including planning and doses and learn the imaging primer for spine including standard and advanced imaging and how to craft individualized plans for primary spinal tumors.
  13. HCC SBRT: Ready for Prime Time: Recognize indications and contraindications for SBRT for hepatocellular carcinoma, demonstrate how to form an individualized plan including contouring planning and avoiding organs and risk and how to follow with modern imaging post treatment.
  14. Oligometastatic Disease and Oligo Progression: Role of RT: State the various definitions of oligometastatic disease, how to plan and execute radiation, understand the benefits and risks and what to evaluate and implement in the setting of oligo progression.
  15. Palliative RT: The Changing Spectrum from Simple to Complex, and from Palliation to Cure: Recognize when to initiate radiation therapy for palliation, how to craft an individual plan to maximize control and minimize time in the cancer center and when and how to treat for long term control or cure.
  16. Cholangiocarcinoma: When to Irradiate?: Describe the indications and contraindications for radiation to cholangiocarcinoma, the use of modern imaging and how to craft a personalized treatment plan, the expectations for outcome and how to follow for progression or recurrence.
  17. NTCP in Clinical Practice : Past – Present and Future: Assimilate the analysis of current NTCP models including the pitfalls and challenges in clinics, an update of current data and expectations for the future.
  18. Billing and Coding: Describe the updates in coding and billing, how to implement the new rules into the clinic and maximize returns and reduce risk.
  19. The Challenges of Larynx and Hypopharynx Cancers: How to Preserve Function: Summarize the appropriate evaluation of larynx and hypopharynx for radiation versus surgery and current trial literature examining the options and outline treatment strategies for advanced disease.
  20. Head & Neck Tumor Board: Examine real-life cases with various treatment alternatives and determine appropriate evaluations that could sway treatment approaches and outline strategies to support one’s point of view in a multidisciplinary discussion.

(c) 2023. Kukuna O Ka La. All Rights Reserved